References
- BauchauVDurhamSRPrevalence and rate of diagnosis of allergic rhinitis in EuropeEur Respir J20042475876415516669
- DahlRAndersenPChivatoTValovirtaEde MonchyJNational prevalence of respiratory allergic disordersRespir Med20049839840315139568
- WeissKBSullivanSDThe health economics of asthma and rhinitis. I. Assessing the economic impactJ Allergy Clin Immunol20011073811149982
- SchatzMA survey of the burden of allergic rhinitis in the USAAllergy200762 Suppl 8591617927673
- NathanRAThe burden of allergic rhinitisAllergy Asthma Proc2007283917390749
- WalkerSKhan-WastiSFletcherMCullinanPHarrisJSheikhASeasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control studyJ Allergy Clin Immunol200712038138717560637
- VuurmanEFvan VeggelLMUiterwijkMMLeutnerDO’HanlonJFSeasonal allergic rhinitis and antihistamine effects on children’s learningAnn Allergy1993711211268346863
- SundbergRTorenKHoglundDAbergNBrismanJNasal symptoms are associated with school performance in adolescentsJ Adolesc Health20074058158317531771
- BousquetJKhaltaevNCruzAAAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)Allergy200863 Suppl 86816018331513
- PlautMValentineMDClinical practice. Allergic rhinitisN Engl J Med20053531934194416267324
- European Medicines AgencyGuideline on the clinical development on products for specific immunotherapy for the treatment of allergic diseases2008 CHMP/EWP/18504/2006
- FrewAJPowellRJCorriganCJDurhamSREfficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitisJ Allergy Clin Immunol200611731932516461133
- DurhamSRWalkerSMVargaEMLong-term clinical efficacy of grass-pollen immunotherapyN Engl J Med199934146847510441602
- DurhamSEmmingerWKappADisease-modifying effect of the SQ-standardised grass allergy immunotherapy tablet is sustained 2 years after treatmentAllergy201065689690
- DahlRStenderARakSSpecific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitisAllergy20066118519016409194
- DahlRKappAColomboGEfficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitisJ Allergy Clin Immunol200611843444016890769
- DahlRKappAColomboGSublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 yearsJ Allergy Clin Immunol200812151251818155284
- FrølundLDurhamSRCalderonMSustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of lifeAllergy20106575375719886920
- NelsonHSNolteHCreticosPMaloneyJWuJBernsteinDIEfficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adultsJ Allergy Clin Immunol2011127728021211643
- BlaissMMaloneyJNolteHGawchikSYaoRSkonerDPEfficacy and safety of Timothy grass allergy immunotherapy tablets in North American children and adolescentsJ Allergy Clin Immunol2011127647121211642
- DurhamSREmmingerWKappALong-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tabletJ Allergy Clin Immunol201012513113820109743
- CalderonMAndersenJSLawtonSMeta-analysis supports that the efficacy of grass allergy immunotherapy tablets is comparable to subcutaneous immunotherapyAllergy2011Suppl 94652653
- MauskopfJASullivanSDAnnemansLPrinciples of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices – budget impact analysisValue Health20071033634717888098
- Danish Medicines and Health AuthorityErfaringer med sundhedsøkonomiske analyser i ansøgninger om generelt tilskud til lægemidler2004 [Danish Medicines and Health Authority. Experiences with health economic analyses in drug reimbursement applications. 2004.]. Available from: http://laegemiddelstyrelsen.dk/da/topics/statistik,-priser-og-tilskud/tilskud-til-medicin/generelletilskud/ansoegning/sundhedsoekonomiske-analyser/erfaringer-medsundhedsoekonomiske-analy-aegemidlerAccessed July 15, 2012 Danish
- Danish Tax and Customs AdministrationSkattesatser 2009–2012 [Tax rates 2009-2012.]. Available from: http://skat.dk/SKAT.aspx?oId=2035568&vId=0&prev=2010&tab=Accessed July 15, 2012 Danish
- Statistics DenmarkEarnings Available from: http://iisboy4.dst.dk/statbank5a/SelectTable/omrade0.asp?Subjectcode=17&PLanguage=1&Shownews=OFF&tree=falseAccessed July 15, 2012
- National Board of Health DenmarkTakstsystem 2010 Vejledning (DAGS fees) [System of charges 2010 instruction (DAGS fees).]. Available from: http://www.sst.dk/publ/Publ2010/SESE/Takst/Takstvejledning_%202010.pdfAccessed July 15, 2012 Danish
- Danish Medical Association§56 Ydelser i dagtiden (wage and fees) [§56 Day time payments (wage and fees).]. Available from: http://www.laeger.dk/portal/page/portal/LAEGERDK/Laegerdk/P_L_O/Overenskomster/Honorartabel/Honorartabel%201-204-12/%C2%A7%2056%20Ydelser%20i%20dagtiden1Accessed July 15, 2012 Danish
- Danish Medicines and Health AuthorityList of medicine prices Available from: http://www.medicinpriser.dk/; http://laegemiddelstyrelsen.dk/da/topics/statistik,-priser-og-tilskud/priser-paa-medicin/prisudvikling/priser-de-seneste-5-aarAccessed July 15, 2012
- GINA Executive CommitteeGlobal Initiative for Asthma; Global Strategy for Asthma Management and Prevention, 2009Bethesda, MDNational Heart, Lung and Blood Institute, National Institute of Health2009
- RadulovicSCalderonMAWilsonDDurhamSSublingual immunotherapy for allergic rhinitisCochrane Database Syst Rev201012CD00289321154351
- PassalacquaGCompalatiECanonicaGWSublingual immunotherapy for allergic rhinitis: an updateCurr Opin Otolaryngol Head Neck Surg201119434721102336
- AndreasenJNLawtonSBæchSBSvärdMCompliance and persistence to grass immunotherapy treatment is comparable for allergy immunotherapy tablets and subcutaneous immunotherapy: a Swedish registry studyAbstract presented at World Allergy CongressDecember 4–8, 2011Cancun, Mexico